| Not Yet Recruiting | Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication Discontinuatio NCT07535892 | University of Alabama at Birmingham | N/A |
| Not Yet Recruiting | Exploring the Influence of Glucagon-like Peptide -1 (GLP-1) Medications on Food Cravings, Food Selection, and NCT07505134 | Penn State University | N/A |
| Not Yet Recruiting | Lifestyle Change Implementation Research Network at PRC at UMass Chan NCT07481305 | University of Massachusetts, Worcester | N/A |
| Recruiting | Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults NCT06811324 | The University of Texas Health Science Center at San Antonio | Phase 2 |
| Not Yet Recruiting | Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer NCT07314528 | St. James's Hospital, Ireland | Phase 2 |
| Recruiting | GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women NCT07422987 | University of Kansas Medical Center | — |
| Recruiting | A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps NCT07437911 | Athletic Greens International | N/A |
| Recruiting | Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder NCT07213466 | Mayo Clinic | Phase 4 |
| Enrolling By Invitation | Multivitamin Impact on Micronutrient Status in GLP-1 Users: A Randomized Trial NCT07234916 | Erasmus Medical Center | N/A |
| Not Yet Recruiting | Impact of Multivitamin (PhytoMulti®) and a Probiotic (UltraFlora® Balance Probiotic) on Gut Health of People T NCT07130396 | Metagenics, Inc. | N/A |
| Not Yet Recruiting | Impact of Probiotic (UltraFlora® Triplebiotic) on Weight Evolution on People After Discontinuation of GLP-1 Tr NCT07209046 | Metagenics, Inc. | N/A |
| Active Not Recruiting | Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese Adults NCT07240246 | FFoQSI - Austrian Competence Centre for Feed and Food Quality, Safety & Innovation | N/A |
| Recruiting | The Effect of Pharmacotherapy With GLP-1 and GIP/GLP-1 Analogs on Changes in Qualitative and Quantitative Para NCT07270497 | Medical University of Warsaw | — |
| Recruiting | The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality NCT07127354 | The Cleveland Clinic | Phase 4 |
| Recruiting | Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy NCT06903923 | University of Virginia | Phase 2 |
| Completed | Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Eff NCT07269821 | University of Alicante | N/A |
| Recruiting | Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity NCT07042672 | Haukeland University Hospital | — |
| Not Yet Recruiting | Impact of GLP-1 Receptor Agonists on Patients With IPMN NCT07014709 | Hôpital Fribourgeois | — |
| Completed | A Trial to Assess Gastrointestinal Responses to Dietary Fibers in Adults Using Weight Loss Medications NCT07012317 | Midwest Center for Metabolic and Cardiovascular Research | N/A |
| Completed | FIT-COACH: Fitbit Intervention With Coordinated Health Coaching and PCP Support NCT06915090 | University of Massachusetts, Worcester | N/A |
| Completed | Glucagon Like Peptide 1 (GLP-1) Booster™ RCT Study NCT07141472 | Lawry Han | N/A |
| Recruiting | MAINTAIN (Mucosal AblatIoN Therapy After INcretins) NCT06734312 | Dr. Christopher McGowan | N/A |
| Recruiting | Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation NCT07092618 | AgelessRx | Phase 2 / Phase 3 |
| Completed | GLP-1 Medicines and Mental Health Changes NCT07368855 | University of California, San Diego | N/A |
| Completed | Effects of GLP-1 Agonists on Gastric Volume NCT05854979 | Medical University of South Carolina | — |
| Completed | Effects of Sucralose in Gut Intestinal Microbiota and Postprandial GLP-1 NCT06094894 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | N/A |
| Active Not Recruiting | Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antips NCT04892199 | Anders Fink-Jensen, MD, DMSci | Phase 4 |
| Completed | The Comparison of PYY, Ghrelin, GLP1, Glucose Level, Level of Satiety, and Ad Libitum Intake in Obese and Non- NCT03701503 | Indonesia University | N/A |